AU2003236044A1 - Drugs for myopia correction surgery - Google Patents

Drugs for myopia correction surgery

Info

Publication number
AU2003236044A1
AU2003236044A1 AU2003236044A AU2003236044A AU2003236044A1 AU 2003236044 A1 AU2003236044 A1 AU 2003236044A1 AU 2003236044 A AU2003236044 A AU 2003236044A AU 2003236044 A AU2003236044 A AU 2003236044A AU 2003236044 A1 AU2003236044 A1 AU 2003236044A1
Authority
AU
Australia
Prior art keywords
drugs
myopia correction
correction surgery
surgery
myopia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003236044A
Inventor
Mayumi Mano
Tomiya Mano
Shunji Sogo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEI Co Ltd
Original Assignee
MEI Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEI Co Ltd filed Critical MEI Co Ltd
Publication of AU2003236044A1 publication Critical patent/AU2003236044A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2003236044A 2002-04-12 2003-04-10 Drugs for myopia correction surgery Abandoned AU2003236044A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002-109992 2002-04-12
JP2002109992A JP2005289814A (en) 2002-04-12 2002-04-12 Medicine for myopia correction surgery
PCT/JP2003/004557 WO2003086465A1 (en) 2002-04-12 2003-04-10 Drugs for myopia correction surgery

Publications (1)

Publication Number Publication Date
AU2003236044A1 true AU2003236044A1 (en) 2003-10-27

Family

ID=29243216

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003236044A Abandoned AU2003236044A1 (en) 2002-04-12 2003-04-10 Drugs for myopia correction surgery

Country Status (3)

Country Link
JP (1) JP2005289814A (en)
AU (1) AU2003236044A1 (en)
WO (1) WO2003086465A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105998030A (en) * 2016-05-17 2016-10-12 温州医科大学 Application of prostaglandin F2a receptor stimulant in preparation of drug for inhibiting myopia and application method of prostaglandin F2a receptor stimulant
WO2021145355A1 (en) * 2020-01-15 2021-07-22 参天製薬株式会社 Pharmaceutical composition for treating myopia, preventing myopia, and/or suppressing progression of myopia
WO2021145356A1 (en) * 2020-01-15 2021-07-22 参天製薬株式会社 Drug composition for treating nearsightedness, preventing nearsightedness, and/or minimizing progression of nearsightedness
EP4266977A1 (en) * 2020-12-23 2023-11-01 Essilor International Method of evaluating the efficiency of a myopia control solution

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3805882C1 (en) * 1988-02-25 1989-07-13 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh, 1000 Berlin, De
TW422696B (en) * 1995-03-20 2001-02-21 Katsuhiko Mukai Ophthalmic composition containing active vitamin D
DE60041963D1 (en) * 1999-01-29 2009-05-20 Senju Pharma Co INHIBITORS OF EYE PRESSURE INCREASE BY LASER RADIATION CONTAINING 1,4-DIHYDROPYRIDINE DERIVATIVES
US6353022B1 (en) * 1999-11-09 2002-03-05 Alcon Universal Ltd. Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
US6414021B1 (en) * 2000-08-25 2002-07-02 Sucampo Ag Control of intraocular pressure during surgery

Also Published As

Publication number Publication date
JP2005289814A (en) 2005-10-20
WO2003086465A1 (en) 2003-10-23

Similar Documents

Publication Publication Date Title
AU2003254553A1 (en) Medical implant
AU2003253106A1 (en) Medical implant
AU2003232258A1 (en) Medical implant
AU2003243150A1 (en) Resorption-controllable medical implants
EP2295053B8 (en) Novel 2H-chromen-2-one-3-carboxamides for medical uses
AU2003215099A1 (en) Anterior spinal implant
AU2003211376A1 (en) Drug administration method
AU2003247151A1 (en) Elastomeric covers for orthopedic implants
AU2003259249A1 (en) Pyridazinylpiperazine derivatives for treating pain
AU2003258298A1 (en) Medical implants
AU2003286552A1 (en) Implantable medical device for improved placement
AU2003263973A1 (en) Open medical system
AU2003234929A1 (en) Therapeutic agent for diabetes
AU2003295890A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
AU2003210515A1 (en) Methods for sterilizing tissue
AU2003277910A1 (en) Ocular gene therapy
AU2003268672A1 (en) Drug absorbability improving agents
AU2003282578A1 (en) Eccentric lumen stents
AU2003270852A1 (en) Patient positioning system
AU2003275709A1 (en) Therapeutic agent for spinal canal stenosis
AU2003241154A1 (en) Navigator-robot for surgical procedures
AU2003223780A1 (en) Treatment for pompe disease
AU2002353487A1 (en) Herbal ophthalmic formulation for preventing cataract
AU2002360752A1 (en) Viscoelastics for ocular surgery
AU2003236044A1 (en) Drugs for myopia correction surgery

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase